Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.77 +0.03 (+4.05%)
At close: Oct 22, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Price to Earnings (2021)

Updated

Creative Medical Technology Holdings' Price to Earnings came in at 0.30 for Q4 2021.

Analysis

Creative Medical Technology Holdings (CELZ) Price to Earnings (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Creative Medical Technology Holdings 1.02 Mn -25.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 0.30
API Access

Creative Medical Technology Holdings Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=CELZ&period=max&api_key=YOUR_API_KEY